{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:18:15Z","timestamp":1791350295924,"version":"4.3.1"},"reference-count":101,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2305,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.jacc.2007.02.052","type":"journal-article","created":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T07:10:51Z","timestamp":1178003451000},"page":"2129-2138","source":"Crossref","is-referenced-by-count":510,"title":["C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk"],"prefix":"10.1016","volume":"49","author":[{"given":"Paul M.","family":"Ridker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2007.02.052_bib1","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2007.02.052_bib2","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/01.CIR.97.20.2007","article-title":"C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0002-9149(90)90079-G","article-title":"Elevation of C-reactive protein in \u201cactive\u201d coronary artery disease","volume":"65","author":"Berk","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2007.02.052_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199408183310701","article-title":"The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina","volume":"331","author":"Liuzzo","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2007.02.052_bib5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/oxfordjournals.aje.a008963","article-title":"Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study","volume":"144","author":"Kuller","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacc.2007.02.052_bib6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(96)07591-5","article-title":"Production of C-reactive protein and risk of coronary events in stable and unstable angina","volume":"349","author":"Haverkate","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2007.02.052_bib7","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2007.02.052_bib8","doi-asserted-by":"crossref","first-page":"A33","DOI":"10.1016\/j.jacc.2006.08.011","article-title":"Inflammation and atherothrombosis from population biology and bench research to clinical practice","volume":"48","author":"Libby","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2007.02.052_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis: an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2007.02.052_bib10","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.CIR.98.8.731","article-title":"Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib11","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2007.02.052_bib12","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","article-title":"Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events","volume":"347","author":"Ridker","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2007.02.052_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.321.7255.199","article-title":"Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses","volume":"321","author":"Danesh","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2007.02.052_bib14","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jama.288.8.980","article-title":"Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women\u2019s Health Initiative observational study","volume":"288","author":"Pradhan","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2007.02.052_bib15","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1161\/01.CIR.0000065228.20100.F7","article-title":"C-reactive protein and the future risk of thromboembolic stroke in healthy men","volume":"107","author":"Curb","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib16","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa040967","article-title":"Inflammatory markers and the risk of coronary heart disease in men and women","volume":"351","author":"Pai","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2007.02.052_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.CIR.99.2.237","volume":"99","author":"Koenig","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib18","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/01.CIR.0000120707.98922.E3","article-title":"C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany","volume":"109","author":"Koenig","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib19","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/01.CIR.0000116763.91992.F1","article-title":"Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study","volume":"109","author":"Ballantyne","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCULATIONAHA.104.504159","article-title":"C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study","volume":"112","author":"Cushman","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib21","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.104.489260","article-title":"C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes","volume":"112","author":"Best","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib22","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/eurheartj\/ehi237","article-title":"C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men: a population-based cohort study","volume":"26","author":"Laaksonen","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2007.02.052_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.atherosclerosis.2005.09.023","article-title":"C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993\u20132003","volume":"187","author":"Boekholdt","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2007.02.052_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/01.CIR.0000055014.62083.05","article-title":"C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib25","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/01.CIR.0000136581.59584.0E","article-title":"C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study","volume":"110","author":"Rutter","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib26","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/01.CIR.0000080897.52664.94","article-title":"Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin-6, and risk of developing type 2 diabetes mellitus","volume":"286","author":"Pradhan","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2007.02.052_bib28","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.2337\/diabetes.51.5.1596","article-title":"C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study","volume":"51","author":"Freeman","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.jacc.2007.02.052_bib29","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00125-004-1472-x","article-title":"C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men","volume":"47","author":"Laaksonen","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacc.2007.02.052_bib30","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1001\/jama.290.22.2945","article-title":"C-reactive protein and the risk of developing hypertension","volume":"290","author":"Sesso","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2007.02.052_bib31","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/01.HYP.0000146691.51307.84","article-title":"Inflammation, abdominal obesity, and smoking as predictors of hypertension","volume":"44","author":"Niskanen","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2007.02.052_bib32","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-145-1-200607040-00128","article-title":"The effect of including C-reactive protein in cardiovascular risk prediction models for women","volume":"145","author":"Cook","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2007.02.052_bib34","unstructured":"Reynolds Risk Score: Calculating Heart and Stroke Risk for Women. Available at: http:\/\/www.ReynoldsRiskScore.org. Accessed February 15, 2007."},{"key":"10.1016\/j.jacc.2007.02.052_bib35","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jama.297.6.611","article-title":"Development and validation of improved algorithms for the assessment of global cardiovascular risk in women","volume":"297","author":"Ridker","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2007.02.052_bib36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.CIR.97.5.425","article-title":"Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib37","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1001\/jama.285.19.2481","article-title":"Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease","volume":"285","author":"Ridker","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2007.02.052_bib38","doi-asserted-by":"crossref","first-page":"690","DOI":"10.2337\/diacare.28.3.690","article-title":"Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein","volume":"28","author":"Malik","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2007.02.052_bib39","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2337\/diacare.27.4.889","article-title":"C-reactive protein and incident cardiovascular events among men with diabetes","volume":"27","author":"Schulze","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2007.02.052_bib40","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","article-title":"Inflammation enhances cardiovascular risk and mortality in hemodialysis patients","volume":"55","author":"Zimmermann","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2007.02.052_bib41","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0272-6386(00)70200-9","article-title":"C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients","volume":"35","author":"Yeun","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2007.02.052_bib42","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jama.290.3.353","article-title":"Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis","volume":"290","author":"deFilippi","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2007.02.052_bib43","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1161\/01.CIR.0000012625.02748.62","article-title":"Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients","volume":"105","author":"Mueller","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib44","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0735-1097(00)01193-1","article-title":"Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation","volume":"37","author":"Walter","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2007.02.052_bib45","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1161\/01.ATV.20.4.1052","article-title":"Serum C-reactive protein and self-reported stroke: findings from the Third National Health and Nutrition Examination Survey","volume":"20","author":"Ford","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2007.02.052_bib46","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1161\/hs1101.098151","article-title":"Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham Study","volume":"32","author":"Rost","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2007.02.052_bib47","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/01.CIR.0000079160.07364.6A","article-title":"C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study","volume":"108","author":"Cao","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib48","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/j.jacc.2006.09.030","article-title":"The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women","volume":"48","author":"Everett","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2007.02.052_bib49","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1161\/01.CIR.0000163569.97918.C0","article-title":"Inflammation and carotid artery risk for atherosclerosis study (ICARAS)","volume":"111","author":"Schillinger","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib50","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/CIRCULATIONAHA.104.506337","article-title":"C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study","volume":"112","author":"vanDijk","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib51","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1161\/01.CIR.0000132467.45278.59","article-title":"Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?","volume":"109","author":"Ridker","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib52","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/archinte.165.21.2473","article-title":"C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study","volume":"165","author":"Wilson","year":"2005","journal-title":"Arch Intern Med"},{"issue":"Suppl II","key":"10.1016\/j.jacc.2007.02.052_bib53","first-page":"II-877","article-title":"Increased CRP and long term risk for cardiovascular events in middle age men and women","volume":"114","author":"Wilson","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib54","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2007.02.052_bib55","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/jama.294.3.326","article-title":"Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women","volume":"294","author":"Ridker","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2007.02.052_bib56","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/archinte.163.11.1323","article-title":"The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study","volume":"163","author":"van der Meer","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2007.02.052_bib57","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/archinte.166.13.1368","article-title":"An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study","volume":"166","author":"Folsom","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2007.02.052_bib58","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1056\/NEJMoa055373","article-title":"Multiple biomarkers for the prediction of first major cardiovascular events and death","volume":"355","author":"Wang","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2007.02.052_bib59","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/CIRCULATIONAHA.106.672402","article-title":"Use and misuse of the ROC curve in the medical literature","volume":"115","author":"Cook","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib60","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/aje\/kwh101","article-title":"Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker","volume":"159","author":"Pepe","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacc.2007.02.052_bib61","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/biostatistics\/kxi005","article-title":"On criteria for evaluating models of absolute risk","volume":"6","author":"Gail","year":"2005","journal-title":"Biostat"},{"key":"10.1016\/j.jacc.2007.02.052_bib62","series-title":"Measures for evaluating model performance","first-page":"253","author":"D\u2019Agostino","year":"1997"},{"key":"10.1016\/j.jacc.2007.02.052_bib63","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00001648-199701000-00002","article-title":"Limitations of sensitivity, specificity, likelihood ratio, and Bayes\u2019 theorem in assessing diagnostic probabilities: a clinical example","volume":"8","author":"Moons","year":"1997","journal-title":"Epidemiology"},{"key":"10.1016\/j.jacc.2007.02.052_bib64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0895-4356(92)90192-P","article-title":"What price perfection?","volume":"45","author":"Diamond","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jacc.2007.02.052_bib65","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.98.9.839","article-title":"Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib66","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.100.3.230","article-title":"Long-term effects of pravastatin on plasma concentration of C-reactive protein","volume":"100","author":"Ridker","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib67","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/01.CIR.103.9.1191","article-title":"Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia","volume":"103","author":"Ridker","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib68","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.286.1.64","article-title":"Effect of statin therapy on C-reactive protein levels: the Pravastatin Inflammation\/CRP Evaluation (PRINCE), a randomized trial and cohort study","volume":"286","author":"Albert","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2007.02.052_bib69","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJM200106283442601","article-title":"Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events","volume":"344","author":"Ridker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2007.02.052_bib70","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/01.CIR.103.15.1933","article-title":"Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels","volume":"103","author":"Jialal","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib71","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-139-8-200310210-00011","article-title":"Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review","volume":"139","author":"Balk","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2007.02.052_bib72","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1161\/01.CIR.0000068312.21969.C8","article-title":"Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial","volume":"107","author":"Ballantyne","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib73","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0002-9149(02)02658-9","article-title":"Effects of simvastatin on C-reactive protein in mixed hyperlipidemic and hypertriglyceridemic patients","volume":"90","author":"Bays","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2007.02.052_bib74","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1161\/01.CIR.0000029743.68247.31","article-title":"Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction","volume":"106","author":"Plenge","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib75","doi-asserted-by":"crossref","first-page":"II18","DOI":"10.1161\/01.CIR.0000129505.34151.23","article-title":"Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?","volume":"109","author":"Schonbeck","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib76","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0195-668X(02)00419-0","article-title":"Statin effects beyond lipid lowering\u2014are they clinically relevant?","volume":"24","author":"Bonetti","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2007.02.052_bib77","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2007.02.052_bib78","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jacc.2005.02.080","article-title":"Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg\/dl and C-reactive protein <2 mg\/l: an analysis of the PROVE-IT TIMI-22 trial","volume":"45","author":"Ridker","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2007.02.052_bib79","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11239-006-8081-0","article-title":"Cholesterol, C-reactive protein, and cerebrovascular events after intensive and moderate statin therapy","volume":"22","author":"Mega","year":"2006","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2007.02.052_bib80","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/CIRCULATIONAHA.106.628909","article-title":"Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial","volume":"114","author":"Morrow","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib81","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa042000","article-title":"Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease","volume":"352","author":"Nissen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2007.02.052_bib82","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.amjcard.2003.07.040","article-title":"Usefulness of lowering low-density lipoprotein cholesterol to <70 mg\/dl and usefulness of C-reactive protein in patient selection","volume":"92","author":"Kent","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2007.02.052_bib83","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/S0735-1097(00)00950-5","article-title":"Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease","volume":"36","author":"Horne","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2007.02.052_bib84","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/01.CIR.0000100688.17280.E6","article-title":"Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial","volume":"108","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib85","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/01.CIR.0000125690.80303.A8","article-title":"Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores","volume":"109","author":"Ridker","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib86","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1161\/CIRCULATIONAHA.105.611350","article-title":"Is C-reactive protein an innocent bystander or proatherogenic culprit?","volume":"113","author":"Scirica","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib87","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/01.HYP.0000130484.20501.df","article-title":"C-reactive protein: risk marker or mediator in atherothrombosis?","volume":"44","author":"Jialal","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2007.02.052_bib88","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1161\/01.ATV.18.9.1386","article-title":"C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries","volume":"18","author":"Torzewski","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2007.02.052_bib89","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1161\/01.CIR.0000131160.94926.6E","article-title":"C-reactive protein promotes monocyte chemoattractant protein-1\u2014mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes","volume":"109","author":"Han","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib90","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/01.CIR.0000033116.22237.F9","article-title":"Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells","volume":"106","author":"Venugopal","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib91","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1182\/blood.V82.2.513.513","article-title":"C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor","volume":"82","author":"Cermak","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2007.02.052_bib92","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/01.CIR.102.9.1000","article-title":"Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease","volume":"102","author":"Fichtlscherer","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib93","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/01.CIR.103.21.2531","article-title":"Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs","volume":"103","author":"Pasceri","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib94","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/01.RES.0000163015.67711.AB","article-title":"Activation of inflammation and coagulation after infusion of C-reactive protein in humans","volume":"96","author":"Bisoendial","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2007.02.052_bib95","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/01.CIR.0000085568.13915.1E","article-title":"Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice","volume":"108","author":"Danenberg","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.052_bib96","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1001\/jama.296.22.2703","article-title":"Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events","volume":"296","author":"Lange","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2007.02.052_bib97","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nm1372","article-title":"Induction of leptin resistance through direct interaction of C-reactive protein with leptin","volume":"12","author":"Chen","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2007.02.052_bib98","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nature04672","article-title":"Targeting C-reactive protein for the treatment of cardiovascular disease","volume":"440","author":"Pepys","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2007.02.052_bib99","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/jama.290.7.898","article-title":"Prevalence of conventional risk factors in patients with coronary heart disease","volume":"290","author":"Khot","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2007.02.052_bib100","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0002-9343(03)00074-3","article-title":"Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia","volume":"114","author":"Blake","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2007.02.052_bib101","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7326\/0003-4819-145-1-200607040-00129","article-title":"Narrative review: assessment of C-reactive protein in risk prediction for cardiovascular disease","volume":"145","author":"Lloyd-Jones","year":"2006","journal-title":"Ann Intern Med"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109707011187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109707011187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T12:36:34Z","timestamp":1587472594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109707011187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":101,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0735109707011187"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2007.02.052","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}